SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001213900-24-094657
Filing Date
2024-11-05
Accepted
2024-11-05 17:55:53
Documents
1
Period of Report
2024-11-01

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 1544
  Complete submission text file 0001213900-24-094657.txt   3124
Mailing Address 112 W. 34TH STREET, 17TH FLOOR NEW YORK NY 10120
Business Address
Dukes Iain D. (Reporting) CIK: 0001681955 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-56377 | Film No.: 241428719

Mailing Address C/O LOMOND THERAPEUTICS HOLDINGS, INC. 8 THE GREEN STE 8490 DOVER DE 19901
Business Address C/O LOMOND THERAPEUTICS HOLDINGS, INC. 8 THE GREEN STE 8490 DOVER DE 19901 561 464 2841
Lomond Therapeutics Holdings, Inc. (Issuer) CIK: 0001900520 (see all company filings)

IRS No.: 872959575 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 6770 Blank Checks
(CF Office: 05 Real Estate & Construction)